{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:40:16Z","timestamp":1793108416316,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Bee venom (BV) is a complex natural secretion of\n                    <jats:italic>Apis mellifera<\/jats:italic>\n                    with documented anti-inflammatory, antimicrobial, and anticancer properties. Despite its therapeutic potential, safety concerns remain due to its strong cytotoxic effects, particularly in sensitive tissues such as the eye. In this study, we evaluated the composition and ocular cytotoxicity of purified BV obtained from the Mu\u011fla ecotype of\n                    <jats:italic>Apis mellifera anatoliaca<\/jats:italic>\n                    . High-performance liquid chromatography with variable wavelength detection (HPLC-VWD) confirmed the presence of three principal components; melittin (71.08\u2009\u00b1\u20090.33%), phospholipase A\u2082 (12.98\u2009\u00b1\u20090.27%), and apamin (3.02\u2009\u00b1\u20090.25%) at retention times consistent with reference standards. Cytotoxicity was assessed in four human ocular cell lines: ARPE-19 (retinal pigment epithelium), NTM5 (trabecular meshwork), HCE-T (corneal epithelium), and HCEC-12 (corneal endothelium), using MTT viability assays and live\/dead staining over 24\u00a0h and 48\u00a0h. BV exerted strong, dose and time dependent cytotoxic effects across all cell lines, with ARPE-19 and NTM5 cells exhibiting the highest sensitivity. IC\u2085\u2080 values were 22.36\u00a0\u00b5g\/mL (24\u00a0h) and 12.55\u00a0\u00b5g\/mL (48\u00a0h) in ARPE-19, and 20.78\u00a0\u00b5g\/mL (24\u00a0h) and 13.07\u00a0\u00b5g\/mL (48\u00a0h) in NTM5 cells. By contrast, HCEC-12 and HCE-T cells displayed moderate sensitivity, with IC\u2085\u2080 values between 29 and 34\u00a0\u00b5g\/mL. These findings highlight tissue-specific differences in BV susceptibility. While BV may offer therapeutic promise, its narrow safety margin in ocular cells underscores the importance of controlled delivery strategies to minimize toxicity. This study provides foundational data for evaluating the ocular safety profile of BV and informs future translational applications.\n                  <\/jats:p>","DOI":"10.1007\/s12013-026-02042-y","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:33:13Z","timestamp":1773214393000},"page":"2907-2920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Vitro Ocular Cytotoxicity of BEE Venom in ARPE-19, NTM5, HCET, and HCEC-12 Cell Lines"],"prefix":"10.1007","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6365-914X","authenticated-orcid":false,"given":"Emine Kubra","family":"Bilir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-8637","authenticated-orcid":false,"given":"Hidayet","family":"Tutun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0475-9092","authenticated-orcid":false,"given":"Sedat","family":"Sevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4860-4300","authenticated-orcid":false,"given":"\u015eeyda","family":"K\u0131vrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-6234","authenticated-orcid":false,"given":"Tommaso","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1954-0256","authenticated-orcid":false,"given":"Rachel","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"2042_CR1","doi-asserted-by":"publisher","unstructured":"Wehbe, R., Frangieh, J., Rima, M., et al. (2019). Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests. Molecules, 24. https:\/\/doi.org\/10.3390\/MOLECULES24162997","DOI":"10.3390\/MOLECULES24162997"},{"key":"2042_CR2","doi-asserted-by":"publisher","first-page":"1412245","DOI":"10.3389\/FPHAR.2024.1412245\/FULL","volume":"15","author":"KM Sadek","year":"2024","unstructured":"Sadek, K. M., Shib, N. A., Taher, E. S., et al. (2024). Harnessing the power of bee venom for therapeutic and regenerative medical applications: an updated review. Frontiers In Pharmacology, 15, 1412245. https:\/\/doi.org\/10.3389\/FPHAR.2024.1412245\/FULL","journal-title":"Frontiers In Pharmacology"},{"key":"2042_CR3","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1007\/S12010-022-04284-X","volume":"195","author":"S Sevin","year":"2023","unstructured":"Sevin, S., Kivrak, \u0130., Tutun, H., et al. (2023b). Apis mellifera anatoliaca Venom Exerted Anti-Inflammatory Activity on LPS-Stimulated Mammalian Macrophages by Reducing the Production of the Inflammatory Cytokines. Applied Biochemistry And Biotechnology, 195, 3194\u20133205. https:\/\/doi.org\/10.1007\/S12010-022-04284-X","journal-title":"Applied Biochemistry And Biotechnology"},{"key":"2042_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.CBI.2007.06.036","volume":"169","author":"YJ Lee","year":"2007","unstructured":"Lee, Y. J., Kang, S. J., Kim, B. M., et al. (2007). Cytotoxicity of honeybee (Apis mellifera) venom in normal human lymphocytes and HL-60 cells. Chem Biol Interact, 169, 189\u2013197. https:\/\/doi.org\/10.1016\/J.CBI.2007.06.036","journal-title":"Chem Biol Interact"},{"key":"2042_CR5","doi-asserted-by":"publisher","unstructured":"NguyenCD, & Lee, G. (2021). Neuroprotective Activity of Melittin-The Main Component of Bee Venom-Against Oxidative Stress Induced by A\u03b225\u201335 in In Vitro and In Vivo Models. Antioxidants (Basel), 10. https:\/\/doi.org\/10.3390\/ANTIOX10111654","DOI":"10.3390\/ANTIOX10111654"},{"key":"2042_CR6","doi-asserted-by":"publisher","unstructured":"Sevin, S., Deveci Ozkan, A., Tutun, H., et al. (2023a). Determination of the Effects of Bee Venom on Triple Negative Breast Cancer Cells in Vitro. Chemistry & Biodiversity, 20. https:\/\/doi.org\/10.1002\/CBDV.202201263","DOI":"10.1002\/CBDV.202201263"},{"key":"2042_CR7","doi-asserted-by":"publisher","unstructured":"G\u00f6kmen, T. G., Yazgan, H., \u00d6zdemir, Y., et al. (2023). Chemical composition and antibacterial activity of bee venom against multi-drug resistant pathogens. Onderstepoort Journal Of Veterinary Research, 90. https:\/\/doi.org\/10.4102\/OJVR.V90I1.2097","DOI":"10.4102\/OJVR.V90I1.2097"},{"key":"2042_CR8","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.molimm.2018.10.016","volume":"103","author":"WN Hozzein","year":"2018","unstructured":"Hozzein, W. N., Badr, G., Badr, B. M., et al. (2018). Bee venom improves diabetic wound healing by protecting functional macrophages from apoptosis and enhancing Nrf2, Ang-1 and Tie-2 signaling. Molecular Immunology, 103, 322\u2013335. https:\/\/doi.org\/10.1016\/j.molimm.2018.10.016","journal-title":"Molecular Immunology"},{"key":"2042_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.55730\/1300-0152.2736","volume":"49","author":"B Orman","year":"2024","unstructured":"Orman, B., Ko\u00e7, A., \u015een Karaman, D., & Nalbantsoy, A. (2024). Intrinsic apoptotic effect of Anatolian honeybee (Apis mellifera anatoliaca) venom promoted with mesoporous silica nanocarriers. Turkish Journal of Biology, 49, 185. https:\/\/doi.org\/10.55730\/1300-0152.2736","journal-title":"Turkish Journal of Biology"},{"key":"2042_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1134\/S0020168515140022","volume":"51","author":"DI Akhmerova","year":"2015","unstructured":"Akhmerova, D. I., Stavrianidi, A. N., Rodin, I. A., & Shpigun, O. A. (2015). Application of high performance liquid chromatography-tandem mass spectrometry for detection of melittin, a characteristic peptide of bee venom. Inorganic Materials, 51, 1431\u20131437. https:\/\/doi.org\/10.1134\/S0020168515140022","journal-title":"Inorganic Materials"},{"key":"2042_CR11","doi-asserted-by":"publisher","unstructured":"Tanuwidjaja, I., Sve\u010dnjak, L., Gugi\u0107, D. (2021). Chemical Profiling and Antimicrobial Properties of Honey Bee (Apis mellifera L.) Venom. Molecules 26:. https:\/\/doi.org\/10.3390\/MOLECULES26103049","DOI":"10.3390\/MOLECULES26103049"},{"key":"2042_CR12","doi-asserted-by":"publisher","unstructured":"Pop, C. E., Miu, B. A., N\u00e9meth, D., et al. (2024). Bisphenol A analysis and quantification inconsistencies via HPLC-UV: a systematic review with technical notes. Discover Applied Sciences, 6. https:\/\/doi.org\/10.1007\/S42452-023-05617-Z","DOI":"10.1007\/S42452-023-05617-Z"},{"key":"2042_CR13","doi-asserted-by":"publisher","unstructured":"Gajski, G., Leonova, E., & Sjakste, N. (2024). Bee Venom: Composition and Anticancer Properties. Toxins (Basel), 16. https:\/\/doi.org\/10.3390\/TOXINS16030117","DOI":"10.3390\/TOXINS16030117"},{"key":"2042_CR14","doi-asserted-by":"publisher","unstructured":"Yoo, J., & Lee, G. (2022). Adverse Events Associated with the Clinical Use of Bee Venom: A Review. Toxins (Basel), 14. https:\/\/doi.org\/10.3390\/TOXINS14080562","DOI":"10.3390\/TOXINS14080562"},{"key":"2042_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5694\/MJA17.01202","volume":"209","author":"AO Payne","year":"2018","unstructured":"Payne, A. O., & Chong, E. (2018). Bee sting to the cornea: toxic effects and management. Medical Journal Of Australia, 209, 155. https:\/\/doi.org\/10.5694\/MJA17.01202","journal-title":"Medical Journal Of Australia"},{"key":"2042_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/AOS.17234","author":"MR Iatissam, Bentouhami","year":"2025","unstructured":"Iatissam, Bentouhami, M. R., Hidan, Y., et al. (2025). Ocular bee sting with retained stinger. Acta Ophthalmologica. https:\/\/doi.org\/10.1111\/AOS.17234. (1755375X) 103:N.PAG.","journal-title":"Acta Ophthalmologica"},{"key":"2042_CR17","doi-asserted-by":"publisher","first-page":"e0126971","DOI":"10.1371\/JOURNAL.PONE.0126971","volume":"10","author":"JH Park","year":"2015","unstructured":"Park, J. H., Yim, B. K., Lee, J. H., et al. (2015). Risk Associated with Bee Venom Therapy: A Systematic Review and Meta-Analysis. PLoS One, 10, e0126971. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0126971","journal-title":"PLoS One"},{"key":"2042_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2131\/JTS.40.295","volume":"40","author":"H Onodera","year":"2015","unstructured":"Onodera, H., Sasaki, S., Otake, S., et al. (2015). General considerations in ocular toxicity risk assessment from the toxicologists\u2019 viewpoints. Journal Of Toxicological Sciences, 40, 295\u2013307. https:\/\/doi.org\/10.2131\/JTS.40.295","journal-title":"Journal Of Toxicological Sciences"},{"key":"2042_CR19","doi-asserted-by":"publisher","unstructured":"Rauchman, S. H., Locke, B., Albert, J. (2023). Toxic External Exposure Leading to Ocular Surface Injury. Vision (Basel) 7:. https:\/\/doi.org\/10.3390\/VISION7020032","DOI":"10.3390\/VISION7020032"},{"key":"2042_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.addr.2018.01.006","volume":"126","author":"M Ziaei","year":"2018","unstructured":"Ziaei, M., Greene, C., & Green, C. R. (2018). Wound healing in the eye: Therapeutic prospects. Advanced Drug Delivery Reviews, 126, 162\u2013176. https:\/\/doi.org\/10.1016\/j.addr.2018.01.006","journal-title":"Advanced Drug Delivery Reviews"},{"key":"2042_CR21","doi-asserted-by":"publisher","unstructured":"Alfonsetti, M., Castelli, V., D\u2019angelo, M., et al. (2021). Looking for In Vitro Models for Retinal Diseases. International Journal Of Molecular Sciences, 22. https:\/\/doi.org\/10.3390\/IJMS221910334","DOI":"10.3390\/IJMS221910334"},{"key":"2042_CR22","doi-asserted-by":"publisher","unstructured":"Cardoso, B. D., Castanheira, E. M. S., Lanceros-M\u00e9ndez, S., & Cardoso, V. F. (2023). Recent Advances on Cell Culture Platforms for In Vitro Drug Screening and Cell Therapies: From Conventional to Microfluidic Strategies. Adv Healthc Mater, 12. https:\/\/doi.org\/10.1002\/ADHM.202202936","DOI":"10.1002\/ADHM.202202936"},{"key":"2042_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.exer.2006.09.022","volume":"84","author":"X Zhang","year":"2007","unstructured":"Zhang, X., Ognibene, C. M., Clark, A. F., & Yorio, T. (2007). Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor \u03b2. Experimental Eye Research, 84, 275\u2013284. https:\/\/doi.org\/10.1016\/j.exer.2006.09.022","journal-title":"Experimental Eye Research"},{"key":"2042_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejps.2017.03.018","volume":"104","author":"M Jureti\u0107","year":"2017","unstructured":"Jureti\u0107, M., Juri\u0161i\u0107 Dukovski, B., Krtali\u0107, I., et al. (2017). HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype? European Journal of Pharmaceutical Sciences, 104, 23\u201330. https:\/\/doi.org\/10.1016\/j.ejps.2017.03.018","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"2042_CR25","doi-asserted-by":"publisher","unstructured":"Kennedy, S., Lace, R., Carserides, C., et al. (2019). Poly-\u03b5-lysine based hydrogels as synthetic substrates for the expansion of corneal endothelial cells for transplantation. J Mater Sci Mater Med, 30. https:\/\/doi.org\/10.1007\/S10856-019-6303-1","DOI":"10.1007\/S10856-019-6303-1"},{"key":"2042_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/J.EXER.2011.09.021","volume":"93","author":"S Mergler","year":"2011","unstructured":"Mergler, S., Valtink, M., Taetz, K., et al. (2011). Characterization of transient receptor potential vanilloid channel 4 (TRPV4) in human corneal endothelial cells. Experimental Eye Research, 93, 710\u2013719. https:\/\/doi.org\/10.1016\/J.EXER.2011.09.021","journal-title":"Experimental Eye Research"},{"key":"2042_CR27","doi-asserted-by":"publisher","unstructured":"Titley, M., Ahmad, S., & Parekh, M. (2021). Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells. J Ophthalmol 2021:. https:\/\/doi.org\/10.1155\/2021\/8392572","DOI":"10.1155\/2021\/8392572"},{"key":"2042_CR28","first-page":"614","volume":"36","author":"K Araki-Sasaki","year":"1995","unstructured":"Araki-Sasaki, K., Ohashi, Y., Sasabe, T., et al. (1995). An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci, 36, 614\u2013621.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2042_CR29","doi-asserted-by":"publisher","unstructured":"Tanu\u011fur-Samanc, A. E., & Keke\u00e7o\u011flu, M. (2021). An evaluation of the chemical content and microbiological contamination of Anatolian bee venom. PLoS One, 16. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0255161","DOI":"10.1371\/JOURNAL.PONE.0255161"},{"key":"2042_CR30","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.fmre.2023.08.011","volume":"4","author":"S Wang","year":"2024","unstructured":"Wang, S., Li, W., Chen, M., et al. (2024). The retinal pigment epithelium: Functions and roles in ocular diseases. Fundamental Research, 4, 1710\u20131718. https:\/\/doi.org\/10.1016\/j.fmre.2023.08.011","journal-title":"Fundamental Research"},{"key":"2042_CR31","doi-asserted-by":"publisher","unstructured":"Yang, S., Zhou, J., & Li, D. (2021). Functions and Diseases of the Retinal Pigment Epithelium. Frontiers In Pharmacology, 12. https:\/\/doi.org\/10.3389\/FPHAR.2021.727870","DOI":"10.3389\/FPHAR.2021.727870"},{"key":"2042_CR32","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1001\/ARCHOPHT.121.10.1423","volume":"121","author":"JD Ho","year":"2003","unstructured":"Ho, J. D., Tsai, R. J. F., Chen, S. N., & Chen, H. C. (2003). Cytotoxicity of indocyanine green on retinal pigment epithelium: implications for macular hole surgery. Archives Of Ophthalmology, 121, 1423\u20131429. https:\/\/doi.org\/10.1001\/ARCHOPHT.121.10.1423","journal-title":"Archives Of Ophthalmology"},{"key":"2042_CR33","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-D\u00edez, M., Romero-Jim\u00e9nez, P., Alegr\u00eda-Aravena, N. (2025). Assessment of Cell Viability in Drug Therapy: IC50 and Other New Time-Independent Indices for Evaluating Chemotherapy Efficacy. Pharmaceutics 2025, Vol 17, Page 247 17:247. https:\/\/doi.org\/10.3390\/PHARMACEUTICS17020247","DOI":"10.3390\/PHARMACEUTICS17020247"},{"key":"2042_CR34","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1167\/IOVS.04-0311","volume":"45","author":"N Strunnikova","year":"2004","unstructured":"Strunnikova, N., Zhang, C., Teichberg, D., et al. (2004). Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest Ophthalmol Vis Sci, 45, 3767\u20133777. https:\/\/doi.org\/10.1167\/IOVS.04-0311","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2042_CR35","doi-asserted-by":"publisher","first-page":"101105","DOI":"10.1016\/j.preteyeres.2022.101105","volume":"91","author":"M Wu","year":"2022","unstructured":"Wu, M., Hill, L. J., Downie, L. E., & Chinnery, H. R. (2022). Neuroimmune crosstalk in the cornea: The role of immune cells in corneal nerve maintenance during homeostasis and inflammation. Progress In Retinal And Eye Research, 91, 101105. https:\/\/doi.org\/10.1016\/j.preteyeres.2022.101105","journal-title":"Progress In Retinal And Eye Research"},{"key":"2042_CR36","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/S41433-025-03619-2","volume":"39","author":"A Shadmani","year":"2025","unstructured":"Shadmani, A., & Wu, A. Y. (2025). Navigating the path to corneal healing success and challenges: a comprehensive overview. Eye (Lond), 39, 1047\u20131055. https:\/\/doi.org\/10.1038\/S41433-025-03619-2","journal-title":"Eye (Lond)"},{"key":"2042_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/S12015-024-10808-1","volume":"21","author":"B Wang","year":"2025","unstructured":"Wang, B., Zhao, J. L., Cai, W. Y., et al. (2025). Progress in Transdifferentiation of Autologous Alternative Cell Sources into Corneal Epithelial Cells. Stem Cell Rev Rep, 21, 226\u2013235. https:\/\/doi.org\/10.1007\/S12015-024-10808-1","journal-title":"Stem Cell Rev Rep"},{"key":"2042_CR38","doi-asserted-by":"publisher","unstructured":"Fan, X., Bilir, E. K., Kingston, O. A., et al. (2021). Replacement of the Trabecular Meshwork Cells-A Way Ahead in IOP Control? Biomolecules, 11. https:\/\/doi.org\/10.3390\/BIOM11091371","DOI":"10.3390\/BIOM11091371"},{"key":"2042_CR39","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.exer.2008.11.008","volume":"88","author":"D WuDunn","year":"2009","unstructured":"WuDunn, D. (2009). Mechanobiology of trabecular meshwork cells. Experimental Eye Research, 88, 718\u2013723. https:\/\/doi.org\/10.1016\/j.exer.2008.11.008","journal-title":"Experimental Eye Research"},{"key":"2042_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.arr.2016.05.012","volume":"29","author":"SC Sacc\u00e0","year":"2016","unstructured":"Sacc\u00e0, S. C., Gandolfi, S., Bagnis, A., et al. (2016). From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma. Ageing Research Reviews, 29, 26\u201341. https:\/\/doi.org\/10.1016\/j.arr.2016.05.012","journal-title":"Ageing Research Reviews"},{"key":"2042_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/CEO.14027","volume":"50","author":"KE Keller","year":"2022","unstructured":"Keller, K. E., & Peters, D. M. (2022). Pathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork-A review. Clinical & Experimental Ophthalmology, 50, 163. https:\/\/doi.org\/10.1111\/CEO.14027","journal-title":"Clinical & Experimental Ophthalmology"},{"key":"2042_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3831\/KPI.2020.23.4.212","volume":"23","author":"SK Borojeni","year":"2020","unstructured":"Borojeni, S. K., Zolfagharian, H., Babaie, M., & Javadi, I. (2020). Cytotoxic Effect of Bee (A. mellifera) Venom on Cancer Cell Lines. J Pharmacopuncture, 23, 212. https:\/\/doi.org\/10.3831\/KPI.2020.23.4.212","journal-title":"J Pharmacopuncture"},{"key":"2042_CR43","doi-asserted-by":"publisher","unstructured":"Pandidan, S., & Mechler, A. (2019). Nano-viscosimetry analysis of the membrane disrupting action of the bee venom peptide melittin. Scientific Reports 2019 9:1 9:10841-. https:\/\/doi.org\/10.1038\/s41598-019-47325-y","DOI":"10.1038\/s41598-019-47325-y"},{"issue":"1 4","key":"2042_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"C Duffy","year":"2020","unstructured":"Duffy, C., Sorolla, A., Wang, E., et al. (2020). Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. npj Precision Oncology 2020, 4(1 4), 24. https:\/\/doi.org\/10.1038\/s41698-020-00129-0","journal-title":"npj Precision Oncology 2020"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-026-02042-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-026-02042-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:51:00Z","timestamp":1781639460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-026-02042-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2042"],"URL":"https:\/\/doi.org\/10.1007\/s12013-026-02042-y","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"28 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The High Resolution Figures has been updated","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not involve human participants, human data, or live vertebrate animals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}